Publication, Part of National Diabetes Inpatient Safety Audit (NDISA)

National Diabetes Inpatient Safety Audit (NDISA) 2018-2021

Audit

Publication Date:: 14 Jul 2022
Geographic Coverage:: England, Wales
Geographical Granularity:: Hospital Trusts
Date Range:: 01 May 2018 to 31 Oct 2021

Current Chapter

View all

Next Chapter

Executive summary

Summary

This report covers: a) the provision of inpatient services in England and Wales on 1 October 2021; and b) diabetes-specific inpatient harms in England between May 2018 and October 2021.

This is the first National Diabetes Inpatient Safety Audit (NDISA) report. NDISA has 2 core components:

A review of inpatient service provision in England and Wales, using the National Diabetes Audit (NDA) Integrated Specialist Services Structures Survey (ISSSS, abbreviated to ISS) undertaken in October 2021. Service provision is assessed against recommendations in the 2020 Diabetes Getting It Right First Time (GIRFT) report.

A review of the rates and risk factors for serious diabetes-specific inpatient harms in England only, using the NDISA harms collection, a mandatory year-round collection of 4 harms that can occur to inpatients with diabetes in acute hospitals in England. The data collection started on 1 May 2018. The collection was previously known as National Diabetes Inpatient Audit (NaDIA) - Harms.

NDISA is part of the NDA programme within the National Clinical Audit and Patient Outcomes Programme (NCAPOP), commissioned by the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS England and the Welsh Government.